mRNA vaccines : A new era in vaccine development
Journal article
Chandra, Shubhra, Wilson, Jennifer C., Good, David and Wei, Ming Q.. (2024). mRNA vaccines : A new era in vaccine development. Oncology Research. 32(10), pp. 1543-1564. https://doi.org/10.32604/or.2024.043987
Authors | Chandra, Shubhra, Wilson, Jennifer C., Good, David and Wei, Ming Q. |
---|---|
Abstract | The advent of RNA therapy, particularly through the development of mRNA cancer vaccines, has ushered in a new era in the field of oncology. This article provides a concise overview of the key principles, recent advancements, and potential implications of mRNA cancer vaccines as a groundbreaking modality in cancer treatment. mRNA cancer vaccines represent a revolutionary approach to combatting cancer by leveraging the body’s innate immune system. These vaccines are designed to deliver specific mRNA sequences encoding cancer-associated antigens, prompting the immune system to recognize and mount a targeted response against malignant cells. This personalized and adaptive nature of mRNA vaccines holds immense potential for addressing the heterogeneity of cancer and tailoring treatments to individual patients. Recent breakthroughs in the development of mRNA vaccines, exemplified by the success of COVID-19 vaccines, have accelerated their application in oncology. The mRNA platform’s versatility allows for the rapid adaptation of vaccine candidates to various cancer types, presenting an agile and promising avenue for therapeutic intervention. Clinical trials of mRNA cancer vaccines have demonstrated encouraging results in terms of safety, immunogenicity, and efficacy. Pioneering candidates, such as BioNTech’s BNT111 and Moderna’s mRNA-4157, have exhibited promising outcomes in targeting melanoma and solid tumors, respectively. These successes underscore the potential of mRNA vaccines to elicit robust and durable anti-cancer immune responses. While the field holds great promise, challenges such as manufacturing complexities and cost considerations need to be addressed for widespread adoption. The development of scalable and cost-effective manufacturing processes, along with ongoing clinical research, will be pivotal in realizing the full potential of mRNA cancer vaccines. Overall, mRNA cancer vaccines represent a cutting-edge therapeutic approach that holds the promise of transforming cancer treatment. As research progresses, addressing challenges and refining manufacturing processes will be crucial in advancing these vaccines from clinical trials to mainstream oncology practice, offering new hope for patients in the fight against cancer. |
Keywords | cancer immunotherapy; immune checkpoint; preventive vaccine; therapeutic vaccine; delivery system; mRNA |
Year | 2024 |
Journal | Oncology Research |
Journal citation | 32 (10), pp. 1543-1564 |
Publisher | Tech Science Press |
ISSN | 0965-0407 |
Digital Object Identifier (DOI) | https://doi.org/10.32604/or.2024.043987 |
PubMed ID | 39308511 |
Scopus EID | 2-s2.0-85204760342 |
PubMed Central ID | PMC11413818 |
Open access | Published as ‘gold’ (paid) open access |
Page range | 1543-1564 |
Publisher's version | License File Access Level Open |
Output status | Published |
Publication dates | |
Online | 18 Sep 2024 |
Publication process dates | |
Accepted | 02 Jul 2024 |
Deposited | 02 Jul 2025 |
Supplemental file | License File Access Level Open |
Additional information | Copyright © 2024 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
https://acuresearchbank.acu.edu.au/item/9202x/mrna-vaccines-a-new-era-in-vaccine-development
Download files
Publisher's version
OA_Chandra_2024_mRNA_vaccines_A_new_era_in.pdf | |
License: CC BY 4.0 | |
File access level: Open |
Supplemental file
OA_Chandra_2024_mRNA_vaccines_A_new_era_in_[GRAPHICAL_ABSTRACT].png | |
License: CC BY 4.0 | |
File access level: Open |
5
total views0
total downloads5
views this month0
downloads this month